Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -2.89% | -12.21% | -32.89% |
Business Summary
Number of employees: 168
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 19-08-06 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 20-04-30 |
Chief Tech/Sci/R&D Officer | 51 | 20-10-31 | |
Eyal Attar
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-10-11 |
Sarah Spencer
IRC | Investor Relations Contact | - | - |
Tania Philipp
HRO | Human Resources Officer | 52 | 19-11-30 |
John C. King
PRN | Corporate Officer/Principal | 49 | 20-07-31 |
General Counsel | 76 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 20-07-29 |
Matt Patterson
CHM | Chairman | 52 | 20-10-19 |
Bob Ang
CEO | Chief Executive Officer | 49 | 19-08-06 |
Bill Lundberg
BRD | Director/Board Member | 60 | 19-02-28 |
Daniella Beckman
BRD | Director/Board Member | 45 | 20-07-15 |
Joshua Resnick
BRD | Director/Board Member | 49 | 19-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,269,901 | 67,481,107 ( 98.84 %) | 0 | 98.84 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.89% | 106M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- VOR Stock
- Company Vor Biopharma Inc.